The promise of a “TrumpRx” website to sell select prescription drugs at reduced prices to cash-paying Americans, along with the administration’s announcement of a deal with Pfizer, may not benefit many Americans, according to an expert.
On Sept. 30, President Donald J. Trump announced an agreement with Pfizer to sell its drug products to Medicaid for much lower prices. Trump also unveiled TrumpRx, a new direct-to-consumer drug website that will sidestep health insurance companies. The website will launch in early 2026, according to a report from Reuters.
These announcements followed an